Navigation Links
Stimulating Thymus Reactivates T-Cell Production
Date:2/22/2008

Finding may provide benefit for HIV, bone marrow transplantation patients

FRIDAY, Feb. 22 (HealthDay News) -- It's possible to stimulate the thymus gland to produce new immune system T-cells in adults infected with HIV, U.S. researchers say.

HIV infection destroys T-cells, which leads to the collapse of the immune system and severe infection. The thymus gland produces T-cells early in life but gradually loses function and becomes mostly inactive in adulthood. That means it's difficult for HIV-infected adults to produce new T-cells to rebuild their depleted immune systems.

It has long been believed that it wasn't possible to reactivate T-cell production in the thymus. The new study, by researchers at the Gladstone Institute of Virology and Immunology and the University of California, San Francisco (UCSF), is the first to show that therapy can help boost thymus function in adults.

The two-year study of 22 HIV-infected adults found that treatment with growth hormone (GH) increased thymus mass and more than doubled the number of newly made T-cells. The results are published in the March issue of the Journal of Clinical Investigation.

"These results represent new proof-of-principle findings that thymic involution can be reversed in humans," study author Dr. Laura Napolitano, an assistant investigator at Gladstone and an assistant professor of medicine at UCSF, said in a prepared statement.

"Improved T-cell production may be helpful for some medical conditions such as HIV disease or bone marrow transplantation. These findings contribute new information to our understanding of T-cell production and are also an important step to determine whether immune therapies might someday benefit patients who need more T-cells," Napolitano said.

However, much more research is needed to determine whether stimulating production of new T-cells actually provides a health benefit for HIV patients or anyone else, the researchers said.

More information

The U.S. Centers for Disease Control and Prevention has more about HIV/AIDS.



-- Robert Preidt



SOURCE: Gladstone Institute, news release, Feb. 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs)
2. Stimulating muscles may improve musicians dystonia
3. Stimulating the appetite can lead to unrelated impulse purchases
4. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
5. EpiVax receives JDRF program funding to develop diabetes drug using natural regulatory T-cells
6. Simulating kernel production influences maize model accuracy
7. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
8. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
9. New study: pine bark extract boosts nitric oxide production
10. New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming
11. BLU-MED Response Systems Announces New Production Facility in Idaho
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stimulating Thymus Reactivates T-Cell Production
(Date:9/25/2017)... ... September 25, 2017 , ... International Water Advocate ... Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on ... focus from a once-every-four-years series of events to a personal, daily Health Olympics. ...
(Date:9/25/2017)... ... , ... Bobbie Horowitz was hardly able to walk without excruciating pain in ... and theater producer, Horowitz would manage to get to rehearsals on time, but wasn’t ... so she had to take a cab everywhere. , It wasn’t until she ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... technology-enabled services supporting clinical research, today announces that 30 of its domain ... the drug development lifecycle at upcoming industry conferences and webinars. Drawing on ...
(Date:9/25/2017)... ... September 25, 2017 , ... Physician Partners of America announces that Chad Gorman, ... as an interventional pain management specialist. , Dr. Gorman is a board-certified physician ... private practice In Brooksville, Fla. His orthopedic background puts him in a unique position ...
(Date:9/25/2017)... New York (PRWEB) , ... September 25, 2017 ... ... Laser & Microsurgery Institute is excited to announce the next generation for LASIK ... Contoura is one of the most technologically advanced laser systems available in the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
Breaking Medicine Technology: